Aarti Drugs Reshuffles Board, Appoints Adhish Patil as Managing Director
Aarti Drugs Ltd has approved a series of changes to its Board of Directors, including the appointment of Adhish Prakash Patil as Managing Director and Nilesh Bhalchandra Patil as Whole-time Director. The changes were approved as part of the company’s 2026 board and governance exercise, with the relevant appointment and reappointment proposals disclosed by the company in July 2026.
The company has also recorded the cessation of Uday Moreshwar Patil as Whole-time Director. Alongside the new appointments, Harshit Manilal Savla has been reappointed as Joint Managing Director, while Harit Pragji Shah has been reappointed as Whole-time Director. Independent directors Hasmukh Bhavanji Dedhia, Sandeep Madhusudan Joshi and Ajit Eledath Venugopalan have also been reappointed.
Adhish P. Patil, who has been serving as Aarti Drugs’ Chief Financial Officer and Chief Operating Officer, has been part of the company’s senior management. The company’s official leadership profile lists his responsibilities across finance and operations.
Harshit M. Savla is the company’s Joint Managing Director, while Harit P. Shah serves as an Executive Director. Uday M. Patil is listed by the company as an Executive Director in its leadership information.
The reappointed independent directors bring experience in finance, business and governance. Aarti Drugs’ official leadership information identifies Hasmukh B. Dedhia, Sandeep M. Joshi and Ajit E. Venugopalan as Independent Directors.
The latest changes mark a transition in Aarti Drugs’ board and management structure, while retaining continuity through the reappointment of senior executive and independent directors. The company’s investor-relations portal lists the 2026-27 appointment and reappointment disclosure, along with its 41st AGM documents.
